Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma
Abstract Glioblastoma multiforme (GBM) is a highly malignant form of cancer that lacks effective treatment options or well‐defined strategies for personalized cancer therapy. The disease has been stratified into distinct molecular subtypes; however, the underlying regulatory circuitry that gives ris...
Main Authors: | Yunpeng Liu, Ning Shi, Aviv Regev, Shan He, Michael T Hemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Molecular Systems Biology |
Subjects: | |
Online Access: | https://doi.org/10.15252/msb.20209506 |
Similar Items
-
PARP-1 protein expression in glioblastoma multiforme
by: A. Galia, et al.
Published: (2012-02-01) -
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer
by: Azeez A. Fatai, et al.
Published: (2018-04-01) -
Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma
by: Jonathan D. Young, et al.
Published: (2017-10-01) -
The regulatory pattern of target gene expression by aberrant enhancer methylation in glioblastoma
by: Ji, J., et al.
Published: (2021) -
Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)